Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV envelope protein (Env) is a complex, trimeric glycoprotein found on the surface of the human immunodeficiency virus (HIV). It plays a critical role in viral entry into host cells by mediating attachment and fusion with the target cell membrane. Env is initially synthesized as a single precursor polyprotein, gp160, which is cleaved into gp120 (receptor binding) and gp41 (membrane fusion). It is the primary target for neutralizing antibodies and an important focus for vaccine and drug development.
Inhibition of gp120 interaction with CD4 receptor, blocking viral entry
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Envelope Protein (Env).